Cargando…

Global gene expression profiling of a mouse model of ovarian clear cell carcinoma caused by ARID1A and PIK3CA mutations implicates a role for inflammatory cytokine signaling

Ovarian clear-cell carcinoma (OCCC) is an aggressive form of epithelial ovarian cancer (EOC). OCCC represents 5–25% of all EOC incidences and is the second leading cause of death from ovarian cancer (Glasspool and McNeish, 2013) [1]. A recent publication by Chandler et al. reported the first mouse m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandler, Ronald L., Raab, Jesse R., Vernon, Mike, Magnuson, Terry, Schisler, Jonathan C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Data in Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583684/ https://www.ncbi.nlm.nih.gov/pubmed/26484281 http://dx.doi.org/10.1016/j.gdata.2015.06.027

Ejemplares similares

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signaling
por: Chandler, Ronald L., et al.
Publicado: (2015)

Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma
por: Zhou, Huan, et al.
Publicado: (2019)

Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma
por: Murakami, Kosuke, et al.
Publicado: (2021)

A girl with CLOVES syndrome with a recurrent PIK3CA somatic mutation and pancreatic steatosis
por: Hanafusa, Hiroaki, et al.
Publicado: (2019)

Somatic mutation in PIK3CA is a late event in cervical carcinogenesis
por: Verlaat, Wina, et al.
Publicado: (2015)

PIK3CA alterations in Middle Eastern ovarian cancers
por: Abubaker, Jehad, et al.
Publicado: (2009)

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma
por: Morikawa, Asuka, et al.
Publicado: (2018)

Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
por: Anabel Sinberger, Liat, et al.
Publicado: (2023)

Clinical analysis and literature review of a case of ovarian clear cell carcinoma with PIK3CA gene mutation: A case report
por: Farah, Abdulkarim Mohamed, et al.
Publicado: (2022)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
por: Sato, Emi, et al.
Publicado: (2018)

A mosaic PIK3CA variant in a young adult with diffuse gastric cancer: case report
por: te Paske, Iris B. A. W., et al.
Publicado: (2021)

A Rare Pathological Phenotype of Endometrioid Serous and Clear-Cell Ovarian Cancer with PIK3CA Mutations in Relation to The Excellent Response of Alpelisib
por: Bayram, Ertugrul, et al.
Publicado: (2023)

Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression
por: Choi, Jae Yoon, et al.
Publicado: (2017)

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
por: Takahashi, Kazuaki, et al.
Publicado: (2021)

Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib
por: Morin, Gabriel, et al.
Publicado: (2022)

PIK3CA mutation in endometriotic epithelial cells promotes viperin-dependent inflammatory response to insulin
por: Wilson, Mike R., et al.
Publicado: (2023)

Asymmetric real-time PCR and multiplex melting curve analysis with TaqMan probes for detecting PIK3CA mutations
por: Botezatu, Irina V., et al.
Publicado: (2015)

Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
por: Maeda, Daichi, et al.
Publicado: (2010)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Identification of novel differentially expressed lncRNA and mRNA transcripts in clear cell renal cell carcinoma by expression profiling
por: Deng, Mario, et al.
Publicado: (2015)

Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer
por: Ibarrola-Villava, Maider, et al.
Publicado: (2015)

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
por: Berns, Katrien, et al.
Publicado: (2018)

Identification and Validation of PIK3CA as a Marker Associated with Prognosis and Immune Infiltration in Renal Clear Cell Carcinoma
por: Li, Ya, et al.
Publicado: (2021)

Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases
por: Ye, Shuang, et al.
Publicado: (2016)

PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014)

CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
por: Kawahara, Naoki, et al.
Publicado: (2021)

Data of a PV plant implemented in hot semi-arid climate
por: Id Omar, Nour-eddine, et al.
Publicado: (2021)

Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes
por: Raab, Jesse R., et al.
Publicado: (2015)

Identification of Two Distinct Classes of the Human INO80 Complex Genome-Wide
por: Runge, John S., et al.
Publicado: (2018)

A Mosaic PIK3CA Mutation in a Moroccan Female: Exploring the Diagnostic Challenges of PIK3CA-Related Overgrowth Spectrum
por: Ahakoud, Mohamed, et al.
Publicado: (2023)

Transcriptional Regulation of PIK3CA Oncogene by NF-κB in Ovarian Cancer Microenvironment
por: Yang, Nuo, et al.
Publicado: (2008)

Expression of Activated PIK3CA in Ovarian Surface Epithelium Results in Hyperplasia but Not Tumor Formation
por: Liang, Shun, et al.
Publicado: (2009)

De novo assembly and comparison of the ovarian transcriptomes of the common Chinese cuttlefish (Sepiella japonica) with different gonadal development
por: Lü, Zhenming, et al.
Publicado: (2015)

Mutations of PIK3CA in gastric adenocarcinoma
por: Li, Vivian Sze Wing, et al.
Publicado: (2005)

Mutations in PIK3CA are infrequent in neuroblastoma
por: Dam, Vincent, et al.
Publicado: (2006)

PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

Draft genome sequence of a monokaryotic model brown-rot fungus Postia (Rhodonia) placenta SB12
por: Gaskell, Jill, et al.
Publicado: (2017)

SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report
por: Wagner, Samantha Kay, et al.
Publicado: (2023)

Version 3 of the Global Aridity Index and Potential Evapotranspiration Database
por: Zomer, Robert J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qtgvsg6g95ihma444075v2bltv